GLP-1 RAs are currently indicated for the treatment of diabetes with cardiovascular disease to improve glycemic control, in addition to weight loss management
Upon arrival, Madison greeted me with a positive attitude and a cold bottle of water
(2) endothelial cells and pericytes1
Weight loss with these medications is also associated with an increased risk of gallbladder problems, including gallstones, which can cause additional digestive symptoms
Healthy Fats The Satiety Sustainer Monounsaturated fats (MUFAs) and omega-3 polyunsaturated fats support GLP-1 release and slow stomach emptying, extending the feeling of fullness beyond the meal window
Lancet 402:720730 Davies MJ, Bajaj HS, Broholm C et al (2025) Cagrilintide-Semaglutide in adults with overweight or obesity and type 2 diabetes